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The renal-specific Na-K-2Cl cotransporter (NKCC2) is the major salt transport pathway of the apical membrane of the
mammalian thick ascending limb of Henle’s loop. Here, we analyze the role of the tetraspan protein myelin and
lymphocytes-associated protein (MAL)/VIP17 in the regulation of NKCC2. We demonstrated that 1) NKCC2 and MAL/
VIP17 colocalize and coimmunoprecipitate in Lilly Laboratories cell porcine kidney cells (LLC-PK1) as well as in rat
kidney medullae, 2) a 150-amino acid stretch of NKCC2 C-terminal tail is involved in the interaction with MAL/VIP17, 3)
MAL/VIP17 increases the cell surface retention of NKCC2 by attenuating its internalization, and 4) this coincides with an
increase in cotransporter phosphorylation. Interestingly, overexpression of MAL/VIP17 in the kidney of transgenic mice
results in cysts formation in distal nephron structures consistent with the hypothesis that MAL/VIP17 plays an important
role in apical sorting or in maintaining the stability of the apical membrane. The NKCC2 expressed in these mice was
highly glycosylated and phosphorylated, suggesting that MAL/VIP17 also is involved in the stabilization of NKCC2 at the
apical membrane in vivo. Thus, the involvement of MAL/VIP17 in the activation and surface expression of NKCC2 could
play an important role in the regulated absorption of Na and Cl in the kidney.
INTRODUCTION
The renal-specific Na-K-2Cl cotransporter (NKCC2) lo-
calizes to the apical membranes of TAL cells in the mam-
malian kidney, where it is responsible for Na and Cl
reabsorption and the maintenance of normal blood pressure.
The central role of the NKCC2 in the vectorial transepithelial
salt reabsorption along the loop of the Henle is evidenced by
the effects of loop diuretics, the pharmacological inhibitors
of NKCC2, that are among the most powerful antihyperten-
sive drugs available to date. Genetic mutations of the
NKCC2 encoding gene have been shown to impair the func-
tion and the apical targeting of NKCC2. The resulting phe-
notype, known as type I Bartter’s syndrome, is characterized
by a severe volume depletion, hypokalemia and metabolic
alkalosis with high prenatal mortality (Simon et al., 1996).
Along with mutations resulting in the loss-of-function of the
cotransporter, others have been identified that disturb its
intracellular trafficking (Pressler et al., 2006).
Moreover, progression from prehypertensive to hyperten-
sive state in spontaneously hypertensive rats (SHRs) is ac-
companied by an increase in steady state protein levels of
NKCC2 and its distribution to plasma membrane compared
with control rats (Sonalker et al., 2004, 2007). Interestingly,
the same amount of NKCC2 m-RNA has been found in both
strains, suggesting that the NKCC2 over expression was due
to a greater translational efficiency or an enhanced stability
of the cotransporter in SHRs.
In addition, TAL tubules from Dahl salt-sensitive (DS)
rats, a model of salt-dependent hypertension, exhibited
significantly higher NKCC2 activity than Dahl salt-resis-
tant strain. Western blot analysis revealed that NKCC2
possessed a different pattern of glycosylation in DS rats,
suggesting that NKCC2 might accumulate at different
stages of its biosynthesis or degradation in these rats
(Alvarez-Guerra and Garay, 2002). These findings under-
line the need to analyze the molecular mechanisms in-
volved in the intracellular trafficking and membrane sta-
bility of NKCC2 to gain insight into the pathophysiology
of salt and water retention.
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It is becoming increasingly clear that ion transport pro-
teins do not exist as isolated units in the membranes of living
cells. Instead, they seem to participate in an extremely wide
array of interactions that help to determine their localiza-
tion, life span, and susceptibility to control by signals trans-
duction machinery.
A new class of interactions has recently been shown to be
relevant to a broad cross-section of renal transport systems.
It has been found that several transport proteins, including
the aquaporin 2 (AQP2) water channel (Kamsteeg et al.,
2007), the Na,K-ATPase (Pagel et al., 2003) and the
H,K-ATPases (Duffield et al., 2003), interact with mem-
bers of the tetraspan family of membrane proteins. Further-
more, these interactions seem to play important roles in
determining the distribution, stability and regulatory prop-
erties of these ion transport proteins.
For example, the tetraspan CD63 has been shown to bind
directly to the -subunit of the H,K-ATPase in parietal
cells of the rat stomach and to be involved in the regulation
of H,K-ATPase trafficking. When coexpressed with CD63,
the H,K-ATPase -subunit is rapidly endocytosed and
accumulates in intracellular vesicles. In contrast, in the ab-
sence of CD63, the H,K-ATPase -subunit accumulates at
the plasmalemma (Duffield et al., 2003).
Moreover, even in the absence of protein-protein interaction,
CD63 plays a role in the regulation of renal outer medullary
potassium (ROMK) channels. In fact, CD63, interacting with
c-Src protein-tyrosine kinase, enhances the inhibitory effect of
this kinase on ROMK channels activity (Lin et al., 2008).
The myelin and lymphocyte-associated protein (MAL),
also known as vesicle integral protein of 17 kDa (VIP17), in
renal epithelial cells is detected exclusively in the apical
plasma membranes (Cheong et al., 1999; Puertollano et al.,
1999). This protein is heavily expressed in distal nephron
segments, TAL, and distal convoluted tubules, as well as in
collecting tubules (Frank et al., 1998). MAL/VIP17 joins a
growing group of tetraspan membrane proteins and is re-
lated to the MARVEL domain-containing class of polypep-
tide (mal and related proteins for vesicle trafficking and
membrane link) (Sa´nchez-Pulido et al., 2002).
Interestingly, overexpression of MAL/VIP17 in the kid-
ney of transgenic mice results in dramatic amplification of
the apical surface and ultimately to cysts formation in distal
nephron structures, consistent with the hypothesis that it
plays an important role in apical sorting or in maintaining
the stability of the apical membranes (Frank et al., 2000).
MAL/VIP17 seems to be associated with and required for
the formation of the detergent insoluble structures variously
referred to as “rafts” or glycolipid- and cholesterol-enriched
membranes. Moreover, recent reports demonstrated that
MAL/VIP17 clusters, formed either by spontaneous cluster-
ing of MAL/VIP17 or by antibody-mediated cross-linking of
FLAG-tagged MAL/VIP17, laterally concentrate markers of
sphingolipid rafts in COS cells, placing MAL/VIP17 as a key
component in the organization of membrane rafts domains
(Goldstein Magal et al., 2009). MAL/VIP17 interacts with
glycosylphosphatidylinositol (GPI)-anchored proteins and
may either escort its associated proteins to the apical mem-
brane or it may retain associated proteins within the apical
membrane (Cheong et al., 1999; Puertollano et al., 1999; Ka-
msteeg et al., 2007; Ramnarayanan et al., 2007).
In this study, we analyzed the interaction of MAL/VIP17
and NKCC2 and the possible physiological role of MAL/
VIP17 in the trafficking and function of NKCC2. Because
NKCC2 is difficult to express in epithelial cells, little is known
about mechanisms that govern the intracellular trafficking and
membrane stability of this cotransporter. Indeed, we previ-
ously generated a chimeric NKCC2 protein that accumulates at
the apical membranes of stably transfected renal epithelial cells
that allows us to explore factors that regulate NKCC2 sorting
and function (Carmosino et al., 2008).
Using LLC-PK1 cells coexpressing a chimeric NKCC2 con-
struct and MAL/VIP17, we showed that MAL/VIP17 stabi-
lized NKCC2 at the apical membrane. Experiments per-
formed in both MAL/VIP17-MDCK deplete cells and MAL/
VIP17-overexpressing mice corroborated this hypothesis.
MATERIALS AND METHODS
Constructs and Antibodies
FLAG-MAL/VIP17 construct has been generated as described previously
(Kamsteeg et al., 2007). The chimeric NKCC2 construct used in this work is
named c-NKCC2 and corresponding to the chimera IV-V described previ-
ously (Carmosino et al., 2008).
The monoclonal T4 antibody was from Developmental Studies Hybridoma
Bank (University of Iowa, Iowa City, IA). The polyclonal R5 antibody was
generated and characterized by Prof. Biff Forbush (Yale University, New Haven,
CT). The polyclonal anti-MAL/VIP17 antibody was from Abcam (Cambridge,
MA). The rabbit polyclonal anti-flotillin-2 and the goat polyclonal anti-actin
antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA). The mono-
clonal anti-hemagglutinin (HA) antibody and both the monoclonal and poly-
clonal anti-FLAG antibodies were from Sigma-Aldrich (St. Louis, MO).
Cell Culture, Transfection, and Animals
LLC-PK1 cells were maintained in DMEM, 2 mM l-glutamine, 10% fetal
bovine serum, penicillin (50 U/ml), and streptomycin (50 U/ml) at 37°C, 5%
CO2 in a humidified incubator. For transfection, cells were grown until 95%
confluent and then cotransfected with HA-tagged c-NKCC2 and with FLAG-
tagged MAL/VIP17. Lipofectamine 2000 (Invitrogen, Carlsbad, CA) was used
for transfection according to the manufacturer’s instructions. Stable clones
were selected in 1 mg/ml geneticin (for cells transfected with HA-tagged
c-NKCC2) and 0.2 mg/ml hygromycin B (for cells transfected with FLAG-
tagged MAL/VIP17).
Kidneys of Wistar-Kyoto rats (from Harlan, Indianapolis, IN) and of trans-
genic MAL/VIP17-overexpressing mice (from Dr. Nicole N. Schaeren-Wiem-
ers, University Hospital Basel, Basel, Switzerland) were used in this work.
MAL/VIP17 Silencing in Madin-Darby Canine Kidney
(MDCK) Cells
A stealth small interfering RNA (siRNA) from Invitrogen targeting dog
MAL/VIP17 was used in combination with Lipofectamine 2000 reagent to
knock down MAL/VIP17 expression in MDCK cells. The relative amounts of
siRNA and Lipofectamine 2000 used in each experiment were decided ac-
cording to the number of plated cells and to the guidelines provided from
Invitrogen. When confluent at 70%, MDCK were treated twice on two con-
secutive days with either scrambled MAL/VIP17 siRNA (MOCK) or MAL/
VIP17 siRNA (MAL/VIP KD).
To analyze MAL/VIP17 knock down, a 60-mm plate of either KD or mock
MDCK cells was lysed in lysis buffer containing 1% Triton X-100 at 4°C. The
lysates was passed through a 22-gauge needle several times. The detergent-
insoluble material was then collected after centrifugation at 13,000 rmp for 15
min. This material was further incubated in lysis buffer supplemented with 60
mM octylglucoside at 37°C for 30 min. After centrifugation at 13,000 rmp for
15 min, the supernatant was recovered and used for the analysis of MAL/
VIP17 expression by SDS-polyacrylamide gel electrophoresis (PAGE) and
Western blotting.
Western blotting was performed using the 2E5 antibody, a rat anti-dog
MAL/VIP17 antibody, kindly provided by Prof. Miguel Alonso (University of
Madrid, Madrid, Spain) and characterized previously in MDCK cells (Puer-
tollano et al., 1999).
Immunofluorescence
Kidneys from rats and mice were fixed in paraformaldehyde 4% in phosphate-
buffered saline (PBS) and than cryoprotected by incubation overnight in sucrose
30% in PBS. Sections of 5 m were cut and mounted on Superfrost Plus glass.
After three washes in PBS, sections were blocked in saturation buffer (1% bovine
serum albumin in PBS) for 20 min at room temperature (RT) and incubated with
the primary antibodies for 2 h at RT (R5, 1:1000; MAL/VIP17, 1:500) in saturation
buffer. After three washes in PBS, sections were incubated with the appropriate
Alexa Fluor-conjugated secondary antibodies for 1 h at RT.
LLC-PK1–transfected cells, grown on 0.4-m cell culture inserts, were fixed
in methanol for 5 min and then subjected to immunofluorescence as described
above. Primary antibodies used were as follows: monoclonal anti-HA anti-
body 1:1000 to detect c-NKCC2 and the polyclonal anti-FLAG antibody 1:1000
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to detect MAL/VIP17. Confocal images were obtained with a laser scanning
fluorescence microscope (TSC-SP2; Leica Microsystems, Deerfield, IL).
Tissues Homogenization and Fractionation
Whole rat kidney was homogenized in ice-cold anti-phosphatase buffer (150
mM NaCl, 30 mM NaF, 5 mM EDTA, 15 mM Na2HPO4, 15 mM pyrophos-
phate, and 20 mM HEPES, pH 7.2) with 2% 3-[(3-cholamidopropyl)dimeth-
ylammonio]propanesulfonate (CHAPS) by using 25 strokes at 25,000 rpm
with a Polytron tissue homogenizer (Brinkmann Instruments, Westbury, NY)
and centrifuged for 10 min at 4000 g at 4°C to pellet debris. Supernatant was
centrifuged for 40 min at 20,000  g at 4°C, and the resulting membranes
containing pellet were resuspended in anti-phosphatase buffer. Membranes
were then used for coimmunoprecipitation (coIP) experiments.
Kidneys of control and MAL/VIP17-overexpressing mice were homoge-
nized in ice-cold anti-phosphatase buffer with 1% Triton X-100 and 0.5 M
calyculin A (CalA) by using Dounce homogenizer. After 30 min of lysis on ice,
lysates were clarified by centrifugation at 13,000  g for 30 min at 4°C. Lysates
were resolved on NuPAGE gels (Invitrogen) and after transfer to Immobilon P
membrane, lanes they were probed with antibodies against: phosphorylated
NKCC2 (R5, 1:1000), total NKCC2 (T4, 1:1000), actin (1:500), and MAL/VIP17
(1:500).
Coimmunoprecipitation Experiments
Rat kidney membranes were precleared with 100 l of protein A-Sepharose
suspension (Sigma-Aldrich) for 1 h at 4°C and then incubated with rabbit
polyclonal antibody to MAL/VIP17 overnight at 4°C under rotation. Immu-
nocomplexes were bound using 100 l of protein A-Sepharose suspension for
2 h at 4°C under rotation and than washed five times with anti-phosphatase
buffer. Immunocomplexes were dissociated in NuPage LDS sample buffer
(Invitrogen) with 100 mM dithiothreitol (DTT), heated at 95°C for 10 min, and
resolved on gel. After transfer to Immobilon P membrane, lanes were probed
with antibodies against NKCC2 (T4, 1:1000) and MAL/VIP17 (MAL/VIP17
rabbit polyclonal antibody, 1:1000).
LLC-PK1 cells cotransfected with c-NKCC2 and MAL/VIP17 were washed
in ice-cold PBS-CM and scraped in anti-phosphatase buffer with 2% CHAPS.
Lysates were clarified by centrifugation at 13,000  g for 15 min at 4°C,
supernatants were precleared with protein A-Sepharose suspension and then
incubated with the polyclonal anti-FLAG antibody (1:1000) overnight at 4°C
under rotation to immunoprecipitate MAL/VIP17. Immunocomplexes were
bound using protein A-Sepharose suspension, washed, dissociated in NuPage
LDS sample buffer, and resolved on NuPAGE gels. After transfer the mem-
brane was incubated with antibodies against NKCC2 (T4, 1:1000) and MAL/
VIP17 (monoclonal anti-FLAG, 1:1000).
Floatation Assay on Discontinuous OptiPrep Gradient
and Detergent Solubility Assay
Transfected LLC-PK1 cells grown on 10-cm-diameter Petri dishes were
washed and scraped in PBS and centrifuged at 1500  g for 5 min. The pellet
was resuspended in isolation medium (150 mM NaCl, 5 mM EDTA, and 25
mM Tris-HCl, pH 7.4, supplemented with protease inhibitors) containing 2%
CHAPS and incubated for 30 min on ice. Two volumes of OptiPrep was
added to 1 volume of lysate and laid at the bottom of an ultracentrifuge tube.
Then, 2 volumes of 35, 30, 25, and 20% (wt/vol) OptiPrep in isolation medium
was gently overlaid on top of the sample and gradient centrifuged at
160,000  g for 4 h at 4°C. Twenty-two fractions of equal volume were
collected from top to bottom of the tube. Ten microliters of each fraction was
separated on NuPAGE gels and assessed by Western blotting for the presence
of NKCC2 (T4, 1:1000), MAL/VIP17 (monoclonal anti-FLAG antibody,
1:1000), and flotillin-2 (anti flotillin-2 antibody, 1:500).
Alternatively, cell lysates were centrifuged at 4°C for 1 h at 100,000 g. The
soluble (supernatant) and insoluble (pellet) fractions (10 g of total proteins)
were separated on NuPAGE gels and assessed by Western blotting for the
presence of the proteins described above.
Endocytosis Assay
Endocytosis assays were performed as described previously (Procino et al.,
2010). In brief, cells grown to confluence were biotinylated with cell-imper-
meable NHS-SS-biotin from the apical side. Cells were returned to 37°C, to
permit internalization of surface proteins, for 1 or 2 h. Next, cells were washed
with ice-cold PBS-CM and treated 3  20 min with ice-cold 150 mM MesNa
in 100 mM NaCl, 1 mM EDTA, 50 mM Tris (pH 8.6), 0.2% BSA. The cell-
impermeable MesNa removes cell surface-bound biotin, whereas internalized
biotinylated proteins are protected. Excess of MesNa was quenched with
ice-cold 120 mM iodoacetic acid in PBS-CM, and cells were lysed. Lysates
were sonicated for 30 s, incubated at 37°C for 20 min and unsolubilized
material was pelleted at 13000 g for 10 min. Biotinylated proteins were
precipitated with streptavidin beads suspension under rotation at 4°C over-
night. Beads were washed and biotinylated proteins were extracted in Nu-
PAGE LDS sample buffer with 100 mM DTT, heated at 95°C for 10 min and
resolved on NuPAGE gels. After transfer Immobilon P membrane was probed
with antibody T4 against NKCC2 (1:1000).
Activation Assay
Cells were preincubated for 30 min in basic medium (135 mM NaCl, 1 mM
MgCl2, 1 mM Na2 SO4, 1 mM CaCl2, and 15 mM Na-HEPES, pH 7,4). Then,
they were incubated for 30 min in low Cl medium (1 mM NaCl, 1 mM
MgCl2, 1 mM Na2 SO4, 1 mM CaCl2, 15 mM Na-HEPES, and 134 mM
Na-gluconate, pH 7,4) or for 15 min in basic medium with 0.5 M protein
phosphatase-1 inhibitor calyculin A (Sigma-Aldrich). After the incubation,
cells were scraped in anti-phosphatase buffer. After lysis on ice for 30 min,
lysates were sonicated and unsolubilized material was pelleted at 13,000  g
for 15 min. Proteins were extracted in NuPAGE LDS sample buffer with 50
mM DTT, heated at 70°C for 10 min, and resolved on NuPAGE gels. After
transfer on membrane lanes were probed with antibody against phosphory-
lated NKCC2 (R5, 1:1000) and total NKCC2 (T4, 1:1000).
Deglycosylation Assay
Proteins (100 g) from lysates of MAL/VIP17-overexpressing mice kidneys
were denaturated in a final volume of 15 l of SDS 1% in PBS for 10 min at
99°C. After denaturation, 15 l of PBS supplemented with protease inhibitors
and 1 l of PNGase F (Sigma-Aldrich), were added, and samples were
incubated for 3 h at 37°C. Proteins were extracted in NuPAGE LDS sample
buffer with 50 mM DTT, heated at 70°C for 10 min, and resolved on NuPAGE
gels. After transfer membrane was probed with antibody T4 against NKCC2
(1:1000).
RESULTS
MAL/VIP17 and NKCC2 Colocalize and
Coimmunoprecipitate in Renal TAL Cells
Previous studies demonstrated that MAL/VIP17 colocalizes
in kidneys with Calbindin-28k, a marker for the connecting
tubule, and AQP2, a marker of principal collecting duct cells
(Kamsteeg et al., 2007). We performed colocalization exper-
iments in rat kidney sections to verify whether NKCC2 and
MAL/VIP17 colocalize in the TAL. To label NKCC2, we
used the polyclonal R5 antibody, which was specifically
raised against a sequence in the NKCC2 N terminus that
contains regulatory phospho-threonines. The utility of this
antibody for immunofluorescence analysis has been well
established (Gimenez and Forbush, 2003). An anti MAL/
VIP17 polyclonal antibody was used to detect MAL/VIP17.
Because both antibodies used were generated in rabbits,
comparison of tubular localization of NKCC2 and MAL/
VIP17 was undertaken using adjacent, serial kidney sections.
NKCC2 (green) and MAL/VIP17 (red) seemed to be ex-
pressed in the same tubular structures. The separate images
were merged, showing that NKCC2 and MAL/VIP17 colo-
calized at the apical membranes of TAL cells (Figure 1A).
To analyze whether MAL/VIP17 and NKCC2 interact in
vivo, we solubilized membranes of kidney medullae by
using 2% CHAPS and used them as starting material for
coIP. Immunoprecipitation with MAL/VIP17 antibodies
and subsequent immunoblotting for NKCC2 using the
monoclonal T4 antibody revealed that NKCC2 indeed coim-
munoprecipitated with MAL/VIP17. A nonimmune serum
(a polyclonal anti-AQP4 antibody) was used a negative con-
trol (n.s.). The Western blotting profile of NKCC2 in kidney
rat membranes clearly showed different bands correspond-
ing to NKCC2 in different stages of maturation. Coimmuno-
precipitation experiments showed that MAL/VIP17 prefer-
entially interacted with the most highly glycosylated form of
NKCC2 (Figure 1A, NKCC2, MAL/VIP17). After being
probed with T4 antibody, membranes were stripped and
incubated with R5 antibody to verify whether NKCC2 also
coimmunoprecipitated with the phosphorylated form of
NKCC2. As shown in Figure 1A, the most highly glycosy-
lated form of NKCC2 is also phosphorylated and coimmu-
noprecipitated with MAL/VIP17 (Figure 1A, p-NKCC2).
We conclude, therefore, that NKCC2 and MAL/VIP17 colo-
calize and interact at the apical membranes of renal TAL
cells.
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MAL/VIP17 Interacts with c-NKCC2 in Renal Transfected
Epithelial Cells and Is Not Involved in the Targeting of
NKCC2 to the Apical Surface
To analyze the role of MAL/VIP17 in the intracellular traf-
ficking of NKCC2, we stably transfected LLC-PK1 cells with
an engineered NKCC2 construct. LLC-PK1 cells are derived
from porcine renal proximal tubule cells that do not express
MAL/VIP17 (Frank et al., 1998). Accordingly, MAL/VIP17
was undetectable in LLC-PK1 cells when assayed by North-
ern blotting (Kamsteeg et al., 2007). For these reasons, we
believed that this cell line was a suitable cellular model to
analyze the effect of the ectopic expression of MAL/VIP17
on the trafficking of NKCC2.
It is well known that NKCC2 is difficult to express stably
in epithelial cells. We previously generated a construct in
which the apical sorting determinants of NKCC2 were ex-
changed into the corresponding region of the NKCC1 C-
terminal tail. The resulting chimera (c-NKCC2) was func-
tionally active and accumulated at the apical membranes of
stably transfected renal epithelial cells (Carmosino et al.,
2008).
Therefore, to achieve the goal of this study we generated
a c-NKCC2 stably transfected LLC-PK1 cell line in which
exogenous MAL/VIP17 was coexpressed when required.
c-NKCC2 and MAL/VIP17 are both tagged at their extreme
N-terminal tails with HA tag and FLAG tag, respectively.
Epitopes were shown previously to not disturb the sorting
and function of both proteins (Puertollano et al., 1999; Car-
mosino et al., 2008). Immunofluorescence experiments
showed that c-NKCC2 and MAL/VIP17 colocalized at the
apical membrane of LLC-PK1 cells. Moreover, they showed
that c-NKCC2 accumulated at the apical membranes of LLC-
PK1 cells regardless of whether exogenous MAL/VIP17 was
coexpressed, suggesting that MAL/VIP17 is not required for
the apical sorting of NKCC2 (Figure 2A).
Coimmunoprecipitation experiments were carried out to
verify whether MAL/VIP17 and c-NKCC2 interact in LLC-
PK1 cells. A polyclonal anti-FLAG antibody was used to
immunoprecipitate MAL/VIP17, and the monoclonal T4 an-
tibody to check for the presence of c-NKCC2 by Western
blotting.
The T4 monoclonal antibody in LLC-PK1 cells, as well as
in many other cell types (Flemmer et al., 2002; Liedtke et al.,
2005; Carmosino et al., 2008), identifies two bands ranging
from 160 to 130 kDa corresponding to a fully and poorly
glycosylated NKCC, respectively. As shown in Figure 2A,
MAL/VIP17 coimmunoprecipitated with the fully glycosy-
lated form of c-NKCC2 when coexpressed in LLC-PK1 cells
(Figure 2A, IP), indicating that MAL/VIP17 and c-NKCC2
interact at the apical membrane.
To further verify whether MAL/VIP17 is involved in the
apical sorting of NKCC2, we knocked down MAL/VIP17
expression in c-NKCC2–transfected MDCK cells, which en-
dogenously expressed MAL/VIP17. The apical localization
of c-NKCC2 was not affected by MAL/VIP17 depletion con-
firming the data obtained in LLC-PK1 cells (Figure 2B).
Western blotting of MAL/VIP17 in detergent-resistant
membrane (DRM) fractions prepared from MDCK, con-
firmed a significant decrease in the MAL/VIP17 expression
in knocked down cells (Figure 2B, MDCK DRMs, MAL/
VIP17), by 70% as quantified by the densitometric analysis
of MAL/VIP17 band (Figure 2B, MAL/VIP17 densitome-
try). Flotillin-2 was used as marker of DRMs and as protein
loading control (Figure 2B, MDCK DRMs, Flo-2).
The C-Terminal Region of NKCC2, Containing the Apical
Sorting Determinants, Is Involved in the Interaction with
MAL/VIP17
To verify whether the interaction between MAL/VIP17 and
NKCC2 was specific, we cotransfected MAL/VIP17 with the
secretory isoform NKCC1 in LLC-PK1 cells. As expected,
NKCC1 was expressed along the basolateral membrane in
LLC-PK1 cells (Figure 2C). Coimmunoprecipitation experi-
ments demonstrated that MAL/VIP17 did not interact with
NKCC1 (Figure 2C), indicating that the interaction between
c-NKCC2 and MAL/VIP17 is specific. An alternative expla-
nation for this result is that, although MAL/VIP17 and
NKCC1 could be able to interact, they are expressed in
distinct membrane domains in polarized epithelial cells (api-
cal for MAL/VIP17 and basolateral for NKCC1). To test this
possibility, we cotransfected MAL/VIP17 and NKCC1 in
unpolarized human embryonic kidney (HEK)-293 cells. In-
terestingly, they did not coimmunoprecipitate even when
expressed in these cells in which they did colocalize at the
plasma membrane (Supplemental Figure 1). These results
clearly showed that the interaction between MAL/VIP17
and c-NKCC2 is actually specific. Because c-NKCC2 is a
chimeric protein between NKCC1 and NKCC2, we can con-
clude that the 150-amino acid stretch of the NKCC2 C-
terminal tail present in the chimera is indeed the region of
NKCC2 necessary for the interaction with MAL/VIP17 (Fig-
ure 2A, chimera structure).
Figure 1. Colocalization and coimmunoprecipitation experiments in rat kidney medulla. (A) Sequential sections of rat kidney were stained
for NKCC2 (green) and MAL/VIP17 (red). The image merge showed that NKCC2 codistributes with MAL/VIP17. (A) Rat kidney medullae
membranes were solubilized in CHAPS and subjected to immunoprecipitation using MAL/VIP17 antibody. Western blotting on kidney
membranes (memb) and Immunoprecipitates (IP) showed that NKCC2 coimmunoprecipitated with MAL/VIP17 (NKCC2). A nonimmune
serum (a polyclonal anti-AQP4 antibody) was used as negative control (n.s.). The same membrane was stripped and subjected to Western
blotting with R5 antibody, showing that also the phosphorylated form of NKCC2 coimmunoprecipitated with MAL/VIP17 (p-NKCC2).
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MAL/VIP17 Decreases the Internalization of c-NKCC2
It has been demonstrated that the MAL/VIP17’s primary role
in the apical sorting of AQP2 may be attributable to the stabi-
lization and retention of AQP2 at the apical surface rather then
to any involvement in its apical delivery (Kamsteeg et al.,
2007). To verify whether this is also true for NKCC2, we
performed an internalization assay for c-NKCC2 on LLC-
PK1 cells in the presence (MAL/VIP17) and in the absence
( MAL/VIP17) of MAL/VIP17. Cells were biotinylated at
4°C on their apical surfaces with cleavable biotin, returned
to 37°C to allow internalization, and then treated with the
membrane-impermeant reducing agent MesNa. Internalized
Figure 2. c-NKCC2 expression in LLC-PK1 and MDCK cells. (A) LLC-PK1 cells stably expressing c-NKCC2 were transfected with
MAL/VIP17. Colocalization experiments were then performed using a monoclonal anti-HA antibody to stain c-NKCC2 (green) and a
polyclonal anti-FLAG antibody to stain MAL/VIP17 (red). The merge showed that c-NKCC2 and MAL/VIP17 colocalize at the apical
membrane. (A) The same cells were lysed in CHAPS and subjected to immunoprecipitation with the polyclonal anti-FLAG antibody.
Western blotting analysis using T4 antibody showed that c-NKCC2 coimmunoprecipitated with MAL/VIP17. The structure of the c-NKCC2
construct is shown on the right of the corresponding Western blotting. The NKCC1 regions are shown in blue, and the NKCC2 regions are
shown in red. (B) Endogenously expressed MAL/VIP17 was knocked down by siRNA in c-NKCC2-transfected MDCK cells. Immunofluo-
rescence showed that c-NKCC2 was expressed at the apical membrane in both control (MOCK) and MAL/VIP17 knocked down cells
(MAL/VIP17 KD). (B) Western blotting of MAL/VIP17 and flotillin-2 (Flo-2) in DRM fractions prepared from MDCK (MDCK DRMs). The
densitometric analysis of the MAL/VIP17 bands showed a decrease of 70% of MAL/VIP17 expression in MAL/VIP7 knocked down cells
(MAL/VIP17 densitometry). Student’s t test, *p  0.0001. (C) LLC-PK1 cells stably expressing NKCC1 were transfected with MAL/VIP17.
The merge showed that NKCC1 and MAL/VIP17 did not colocalize. (C) The same cells were lysed in CHAPS and subjected to
immunoprecipitation with the polyclonal anti-FLAG antibody. Western blotting analysis using T4 antibody showed that NKCC1 did not
coimmunoprecipitate with MAL/VIP17.
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c-NKCC2 was protected from cleavage and thus recovered
by immobilized streptavidin. As shown in Figure 3A, more
c-NKCC2 was protected from MesNa cleavage at each suc-
cessive time point (1–2 h) in MAL/VIP17 lacking cells com-
pared with MAL/VIP17-transfected cells. These data sug-
gest that MAL/VIP17 decreases the internalization of
c-NKCC2 in LLC-PK1 cells. Interestingly, the knockdown of
MAL/VIP17 in MDCK cells increased the rate of c-NKCC2
internalization by 35% at each successive time points,
confirming that MAL/VIP17 is involved in stabilizing
NKCC2 at the apical membrane in MDCK as well as in
LLC-PK1 cells (Figure 3B).
MAL/VIP17-dependent Phosphorylation Dynamics of
c-NKCC2: MAL/VIP17 Increases the Fraction of
Phosphorylated/Phosphorylatable c-NKCC2
Three phospho-acceptor threonines in the N terminus of
NKCC1 and NKCC2 have been identified as key elements in
the NKCC1 cotransporter activation (Darman and Forbush,
2002). Because this region is well conserved both across
species and between isoforms, it is an excellent candidate as
a universal regulatory motif for NKCCs.
NKCCs are activated under conditions in which cells are
depleted of cytosolic chloride, and we have routinely used
low Cl preincubation to stimulate the chloride transport
mediated by NKCCs in mammalian cells (see Materials and
Methods). To analyze the activation dynamics of c-NKCC2
expressed in LLC-PK1 cells, cells were preincubated for 30
min in basic medium (see Materials and Methods). A group of
cells were then incubated in low Cl medium or with 0.5 M
CalA, a specific protein phosphatase-1 inhibitor, in basic
medium for 30 min. Cells were then lysed and the phos-
phorylation state of c-NKCC2 was evaluated by Western
blotting using the R5 antibody, specifically raised against the
conserved phospho-threonines in the N-terminus of NKCCs.
Figure 4A showed that the phosphorylation state of c-
NKCC2 increased in LLC-PK1 cell upon ectopic expression
of MAL/VIP17 in all the experimental conditions (Figure
4A, CTR, low Cl, CalA). The amount of total c-NKCC2,
revealed using the T4 antibody, was unchanged in all the
experimental conditions. Densitometric analysis of the R5
bands, normalized for the T4 signals, showed that the phos-
phorylation state of c-NKCC2 was significantly increased by
30  0.24, 51.6  0.4, and 42.1  0.3% in control, low
chloride, and CalA conditions, respectively, after the ectopic
expression of MAL/VIP17 (Figure 4B). In contrast, the
knockdown of MAL/VIP17 expression in MDCK cells
clearly decreased the phosphorylation state of c-NKCC2 in
both control and low Cl conditions (Figure 4C). Densito-
metric analysis of the phosphorylated/phosphorylatable
Figure 3. Internalization experiments. (A) LLC-PK1 cells expressing c-NKCC2 alone or in combination with MAL/VIP17 were grown to
confluence and biotinylated from their apical side by using a cleavable biotin. Cells were then allowed to internalize surface-labeled proteins
for the indicated times. The remaining surface accessible biotin was then stripped with MesNa where indicated (MesNa, ). Biotinylated
proteins were then recovered and immunoblotted for NKCC2. Each experimental condition was examined in triplicate. Internalized
c-NKCC2 was determined from three independent experiments by densitometry of biotinylated c-NKCC2 at 1 and 2 h of internalization and
expressed as percentage of total cell surface c-NKCC2 (MesNa , intern. h 0). Student’s t test, **p  0.0001. (B) Control (mock) and
MAL/VIP17 knocked down (MAL/VIP17 KD) MDCK cells were subjected to the same assay described above. Each experimental condition
was examined in triplicate. Internalized c-NKCC2 was determined from three independent experiments by densitometry of biotinylated
c-NKCC2 at 1 and 2 h of internalization and expressed as percentage of total cell surface c-NKCC2 (MesNa , intern. h 0). Student’s t test,
*p  0.005.
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(p)-c-NKCC2 bands, normalized for the total c-NKCC2,
showed that in MAL/VIP17-depleted MDCK cells the extent
of c-NKCC2 phosphorylation decreased by 44.4  0.3 and
42  0.25% in control and low Cl conditions respectively
(Figure 4D). Altogether, these results indicate that the pres-
ence of MAL/VIP17 increases the fraction of phosphorylat-
ed/phosphorylatable c-NKCC2 in both LLC-PK1 and
MDCK cells.
One explanation for these results is based on the possibil-
ity that MAL/VIP17 preferentially interacts with and stabi-
lizes the phosphorylated form of c-NKCC2. To verify this
hypothesis, we performed coimmunoprecpitation experi-
ments either in control or in low Cl activated LLC-PK1
cells. As show in Figure 5A, the phosphorylation state of the
cotrasporter, analyzed using R5 antibody, increased in low
Cl condition (lysates, low Cl) and MAL/VIP17 was able
Figure 4. Phosphorylation dynamics of NKCC2 in the absence or in the presence of MAL/VIP17. (A) LLC-PK1cells expressing c-NKCC2
alone or in combination with MAL/VIP17 were grown to confluence on 12-well plates, incubated in low Cl medium or in the presence of
0.5 M CalA. Cells were then lysed and subjected to Western blotting using R5 antibody. The same nitrocellulose membranes were stripped
and reprobed by Western blotting with T4 antibody. Each experimental condition was examined in quadruplicate. (B) The quantitation of
phosphorylated c-NKCC2 was determined from three independent experiments by densitometry of phospho-c-NKCC2 bands (R5 signal)
normalized for the corresponding c-NKCC2 bands (T4 signal). Student’s t test, *p  0.001, **p  0.0001. (C) Both control (MOCK) and
MAL/VIP17-depleted MDCK cells (MAL/VIP17 KD) were incubated in regular or low Cl medium. Cells were then lysed and subjected to
Western blotting using R5 antibody (p-c-NKCC2). The same nitrocellulose membranes were stripped and reprobed by Western blotting with
T4 antibody (c-NKCC2). Each experimental condition was examined in triplicate. (D) The quantitation of phosphorylated c-NKCC2 was
determined from three independent experiments by densitometry of phospho-c-NKCC2 bands (p-c-NKCC2) normalized for the correspond-
ing c-NKCC2 bands (c-NKCC2). Student’s t test, **p  0.0001.
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to interact with the phosphorylated form of c-NKCC2 (Fig-
ure 5A, IP, low Cl). However, the amount of total c-NKCC2
(detected with T4 antibody) that coimmunoprecipitates with
MAL/VIP17 did not increase when cells were incubated in
low Cl solution (Figure 5B). This suggests that MAL/VIP17
does not preferentially interact with the phosphorylated
form of c-NKCC2.
Another possible explanation for the increased phosphor-
ylation of c-NKCC2 in MAL/VIP17-expressing LLC-PK1
cells is that MAL/VIP17 binds both to NKCC2 and to ele-
ments of the NKCC2 activation machinery. However, we
found that neither the STE20/SPS1-related proline/alanine-
rich kinase (SPAK) kinase nor the protein phosphatase-1, the
major players in the NKCC activation, coimmunoprecipitate
with MAL/VIP17 (Supplemental Figure 2).
MAL/VIP17 Is Not Involved in the Association of
c-NKCC2 with DRMs
MAL/VIP17 protein is present in DRMs and interacts with
GPI-apical proteins. Indeed, is thought to play a role in the
incorporation of cargo into these membrane subdomains.
We performed a floatation assay to verify whether the in-
troduction of MAL/VIP17 into LLC-PK1 cells induces incor-
poration of c-NKCC2 into the DRMs. By convention, DRMs
are considered to be membrane domains that are insoluble
when lysed at 4°C in 1% Triton X-100. Indeed, we first
performed the floatation assay in these experimental condi-
tions. However, we found that in MAL/VIP17-negative
LLC-PK1 cells only a small pool of the cotransporter is
associated with Triton-resistant DRMs and that the coex-
pression of MAL/VIP17 with c-NKCC2 in these cells did not
result in a further recruitment of c-NKCC2 into DRMs (Sup-
plemental Figure 3A).
Because MAL/VIP17 and c-NKCC2 coimmunoprecipi-
tated when cells were lysed in a mild detergent such as
CHAPS, we performed the floatation assay after extracting
the cells in cold 2% CHAPS (see Materials and Methods). As
shown in Figure 6A, MAL/VIP17 and flotillin-2 behaved
similarly thus floating exclusively to the lighter fractions,
demonstrating that they were included in the DRMs (Figure
6A, Flo-2, MAL/VIP17). Moreover, c-NKCC2 is mainly ex-
pressed in the lighter fractions regardless of whether the
MAL/VIP17 is ectopically expressed, suggesting that
c-NKCC2 per se is included in CHAPS-resistant DRMs in
LLC-PK1 cells (Figure 6A, c-NKCC2). We obtained the same
results in lysates from rat kidney medullae (Supplemental
Figure 3B).
We next investigated whether p-NKCC2, as well as the
total NKCC2, is preferentially associated with DRMs and
whether the presence of MAL/VIP17 might regulates this
association. Because the detection of phosphorylated
NKCC2 with R5 antibody requires a rapid processing of the
sample, we addressed this issue by a detergent solubility
assay (see Materials and Methods).
As shown in Figure 6B, p-NKCC2 was mainly expressed
in the insoluble fraction regardless of whether MAL/VIP17
is ectopically expressed (Figure 6B, p-NKCC2). The same
samples were assayed for the presence of flotillin-2 and
MAL/VIP17. Both Flo-2 and MAL/VIP17 were expressed
only in the insoluble fraction, indicating that this experimen-
tal procedure can actually separate rafts versus nonrafts
membranes (Figure 6B, Flo-2, MAL/VIP17).
The samples were then probed with T4 to visualize the
distribution of the total NKCC2 among the insoluble- and
soluble-detergent fractions. As shown in Figure 6B, the
total c-NKCC2 behaved similarly to p-NKCC2, confirming
the results obtained in the floatation assay (Figure 6B,
c-NKCC2).
Overall, the experiments conducted in LLC-PK1 and
MDCK cells indicate that 1) a 150-amino acid stretch of
NKCC2 C-terminal tail is involved in the interaction with
MAL/VIP17, 2) MAL/VIP17 is not involved in the apical
surface delivery of c-NKCC2 but rather in the stabilization of
the cotransporter at the apical membrane domain, 3) this
coincides with an increase in the phosphorylation level of
c-NKCC2 in both basal and activating conditions, and 4)
MAL/VIP17 does not induce any further recruitment of
c-NKCC2 into a subpopulation of DRMs.
NKCC2 Expression in MAL/VIP17-overexpressing
Transgenic Mice
Transgenic animals are widely used to understand the phys-
iological role and regulation of several membrane proteins.
Because MAL/VIP17 has been characterized as an addi-
tional myelin component (Frank et al., 1999; Erne et al., 2002),
transgenic mice overexpressing MAL/VIP17 have been gen-
erated to gain more insight into the functional roles of
MAL/VIP17 in myelin formation (Frank et al., 2000). Beside
the myelin alteration in the CNS, Frank et al. (2000) found
the formation of large cysts in the kidney tubules of these
transgenic mice. This observation is consistent with dra-
matic amplification of the apical surface of the renal epithe-
lial cells and with the hypothesis that MAL/VIP17 plays an
important role in apical sorting or in maintaining the stabil-
ity of the apical membranes.
We analyzed the expression and regulation of NKCC2 in
the kidneys of these mice. Western blot analysis of whole
kidney lysates clearly showed an increase in the extent of
NKCC2 glycosylation as well as MAL/VIP17 expression in
transgenic mice compared with wild-type littermates (Fig-
ure 7A, gly-NKCC2, MAL/VIP17). Densitometric analysis of
the broad band centered at 160 kDa, normalized to the
Figure 5. Coimmunoprecipitation of c-NKCC2
and MAL/VIP17 in CTR and low Cl condi-
tions. LLC-PK1 cells expressing c-NKCC2 and
MAL/VIP17 were incubated in CTR or low Cl
conditions, lysed in 2% CHAPS, and subjected to
immunoprecipitatation with anti-FLAG anti-
body. Western blotting analysis was made with
R5 (A) or T4 (B) antibodies. The phosphorylation
of the cotransporter in low Cl did not change
the apparent affinity of c-NKCC2 for MAL/
VIP17.
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corresponding actin band, showed that the band corre-
sponding to glycosylated NKCC2 increased by 40% in
transgenic mice compared with control mice (Figure 7A).
To verify that the broad band centered at 160 kDa actually
corresponds to the glycosylated form of NKCC2, we treated
kidney lysates from MAL/VIP17 transgenic mice with pep-
tide-N-(N-acetyl--glucosaminyl)asparagine amidase (PN-
Gase F). As shown in Figure 7A, glycosidase treatment
shifted the molecular mass of the NKCC2-immunoreactive
broad band to 135 kDa. Moreover, Western blotting anal-
ysis of whole kidney lysates using the R5 antibody showed
that NKCC2 was more heavily phosphorylated in transgenic
mice compared with control mice (Figure 7B). Densitometric
analysis of the R5-reactive band clearly showed in increase
in NKCC2 phosphorylation by 40% in transgenic mice
(Figure 7B).
Accordingly, immunofluorescence experiments using R5
antibody showed a strong labeling of the cells lining the
cysts, as well as the apical membrane of TAL tubules, in
transgenic mice. In contrast, very faint or absent labeling
was found in control mice (Figure 7C). The increase in both
NKCC2 glycosylation and phosphorylation observed in
MAL/VIP17-overexpressing mice might be consistent with
an increase in NKCC2 membrane stability in those animals,
corroborating the results obtained in MAL/VIP17-express-
ing LLC-PK1 cells.
DISCUSSION
We find that in the kidney, the NKCC2 cotransporter colo-
calizes and interacts with MAL/VIP17, which shares fea-
tures with members of the tetraspan and MARVEL family of
Figure 6. Floatation and detergent solubility assays in LLC-PK1 cells transfected with c-NKCC2 alone or in combination with MAL/VIP17.
(A) LLC-PK1 cells were lysed in 2% CHAPS at 4°C. Lysates were then subjected to floatation assay as described in Materials and Methods.
Twenty-two fractions, taken from the top to the bottom of the gradient, were subjected to immunoblotting with antibodies specific for the
membrane proteins indicated on the right. These data are representative of three independent experiments. The expression of MAL/VIP17
did not induce any further recruitment of c-NKCC2 into DRMs. (B) LLC-PK1 cells were lysed in 2% CHAPS at 4°C. Lysates were then
fractionated into supernatant (soluble fraction) and pellet (insoluble fraction), and equal amounts of total proteins was analyzed by
SDS-PAGE followed by immunoblotting with antibodies specific for the membrane proteins indicated on the right. The expression of
MAL/VIP17 did not induce any further recruitment of p-c-NKCC2 into DRMs.
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proteins. This observation suggests that these families of
polypeptides constitute a new collection of membrane pro-
teins involved in regulating the distribution and function of
renal transporters.
Several of the tetraspan proteins were first identified as
surface antigens on cells of the immune system, as reflected
in their inclusion in the “cluster of differentiation (CD)”
system of nomenclature (Hammond et al., 1998; Levy et al.,
1998). The expression of the tetraspan proteins has been
found not to be limited, however, to cells of bone marrow
origin. Most of the tetraspans are found in a wide variety of
cell types, including epithelia, neurons, glia, endothelia, and
smooth and striated muscle (Okochi et al., 1999; Fradkin et
al., 2002; Zhang et al., 2009) where they are involved in
several physiological events such as cell motility and adhe-
sion, fertility, vision, and brain development (Caplan et al.,
2007; Charrin et al., 2009).
Here, we identified a functional role for the interaction
between NKCC2 and MAL/VIP17 in regulating the surface
expression of NKCC2. This finding is novel and interesting,
because very little is known about NKCC2 intracellular traf-
ficking, membrane stability and regulation due to the diffi-
culty inherent in stably expressing NKCC2 in epithelial cells.
The N-terminal tail of NKCC2 is a critical region of the
protein that is required for its stable expression in epithelial
cells (Isenring et al., 1998). Thus, we previously generated a
Figure 7. Analysis of NKCC2 and p-NKCC2 in control and
MAL/VIP17-overexpressing transgenic mice. Kidneys from
three control (CTR) and three transgenic (OVER-MAL/VIP17)
mice were lysed in antiphosphatase buffer with 1% Triton X-100
and subjected to immunoblotting. (A) Western blotting was
made with anti-NKCC2 (T4), anti-actin, and MAL/VIP17 anti-
bodies. (A) Densitometric analysis of the 130- to 160-kDa broad
band revealed by T4 antibody, corresponding to the glycosylated
form of NKCC2 (gly-NKCC2) in both strains of mice. Values
were normalized for -actin signal. (A) Western blotting analy-
sis was made with anti-NKCC (T4) in kidney lysates from MAL/
VIP17-overexpressing transgenic mice after incubation without
() or with () PNGase F. The Western blotting reported is
representative of three independent experiments. (B) Western
blotting was made with anti-phospho-NKCC (R5) or anti-actin
antibodies. (B) Densitometric analysis of the 160-kDa band re-
vealed by R5 antibody, normalized for -actin signal, in both strains of mice. The densitometric values are expressed as mean  SE of three
independent experiments. Student’s t test, *p  0.001. (C) Sections from paraformaldehyde-fixed kidneys of control or transgenic mice were
subjected to immunofluorescence with R5 antibody. Images were collected with a confocal laser-scanning microscope from kidneys of three
control and three transgenic mice. Two representative pictures are presented. The staining with R5 was present in cells lining the cysts (C)
as well as in normal tubules (T) in MAL/VIP17-transgenic mice (OVER-MAL/VIP17). The staining is absent in kidneys from control mice.
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chimeric NKCC construct in which the apical sorting deter-
minants of NKCC2, identified in its C terminus, has been
exchanged into the NKCC1 backbone (Carmosino et al.,
2008). The resulting chimera (that we refer to as c-NKCC2
here) is selectively expressed at the apical domain in epithe-
lial cells and it is functionally active, thus rendering it a
useful tool for studying the regulation of NKCC2 in an
epithelial cell system.
Experiments performed in LLC-PK1 cells cotransfected
with c-NKCC2 and MAL/VIP17 demonstrated that the chi-
mera selectively colocalizes at the apical membrane and
interacts with MAL/VIP17.
Interactions of tetraspan family proteins with partner pro-
teins can be formed via different structural domains. For
example, CD81 associates with the extracellular domain of
immunoglobulin CD19 (Matsumoto et al., 1993) and with the
intracellular domain of another partner immunoglobulin
EWI-2 (Stipp et al., 2001). Moreover, CD151 interacts with
the extracellular domains of 3-integrin (Yauch et al., 2000).
Taking advantage of the chimeric NKCC2 protein used in
this work, we have been able to map in the NKCC2 the
region of its interaction with MAL/VIP17. NKCC1 was not
able to coimmunoprecipitate with MAL/VIP17 even when
the two proteins colocalize at the plasma membrane in HEK
cells, suggesting that the 150-C–terminal amino acid stretch
of NKCC2 present in the chimeric construct is involved in
the interaction with MAL/VIP17.
Localization experiments showed that c-NKCC2 is deliv-
ered to the apical membrane in LLC-PK1 cells indepen-
dently of MAL/VIP17 ectopic expression, suggesting that
MAL/VIP17 is not required for the apical sorting of NKCC2.
It has been demonstrated previously that MAL/VIP17 plays
an important role in the transport of apical proteins from the
trans-Golgi network to the apical plasma membrane in
MDCK cells. The expression of antisense RNA directed
against MAL/VIP17 in MDCK cells caused accumulation in
the Golgi and/or impaired apical transport of different api-
cal protein markers, such as influenza virus hemagglutinin,
the secretory protein clusterin (gp8O), the transmembrane
protein gpll4, and a glycosylphosphatidylinositol-anchored
protein (Cheong et al., 1999). However, we showed in this
paper that knockdown of MAL/VIP17 expression by siRNA
did not affect the apical sorting of NKCC2 in MDCK cells.
Moreover, it is also worth noting that both LLC-PK1 cells
and the Caco-2 human colon carcinoma cell line (de Marco et
al., 2002) express no endogenous MAL/VIP17, although the
influenza HA protein is still sorted to the apical plasma
membrane in these cell types (Roush et al., 1998; Riento et al.,
2000). Rather, we demonstrated that the interaction with
MAL/VIP17 stabilizes c-NKCC2 at the apical membrane of
LLC-PK1 and MDCK cells by inhibiting the steady-state rate
of endocytosis of this protein.
This result is in agreement with the previous observation
that the interaction with MAL/VIP17 slows the internalization
of AQP2, resulting in an increase in the population of this
water channel that is present in the apical membrane in the
absence of hormonal stimulation (Kamsteeg et al., 2007).
Moreover, using the R5 antibody that is specifically directed
against phosphorylated NKCCs, we showed that the stabi-
lization of c-NKCC2 at the apical membrane of MAL/VIP17
expressing LLC-PK1 coincides with an increase in the extent
of cotransporter phosphorylation.
It has been demonstrated that the activation of NKCC
cotrasporters occurs upon their phosphorylation at three
conserved threonines in the N terminus. The reactivity of a
polyclonal antibody directed against these phospho-threoni-
nes (R5 antibody) with NKCCs directly mirrors their func-
tional activation as assayed by rubidium fluxes (Flemmer et
al., 2002). Thus, we can speculate that the increase in the
extent of NKCC2 phosphorylation observed after the ectopic
expression of MAL/VIP17 in LLC-PK1 cells (either in steady
state or under activating conditions), coincides with an in-
crease in NKCC2 activation. Possible explanations for the
increased phosphorylation of c-NKCC2 in MAL/VIP17-ex-
pressing LLC-PK1 cells include 1) MAL/VIP17 preferen-
tially interacts with phosphorylated c-NKCC2, or 2) MAL/
VIP17 also binds to elements of the NKCC2 activation
machinery.
We tested the first possibility by comparing the amounts
of c-NKCC2 present in the MAL/VIP17 immunoprecipitates
in the control condition and after low Cl preincubation.
The phosphorylation of the cotransporter after incubation in
low Cl solution did not change its affinity for MAL/VIP17.
Intracellular chloride depletion activates NKCC2 by promot-
ing the phosphorylation of three highly conserved threoni-
nes (96, 101, and 111) in the amino terminus. The chloride-
sensitive activation of NKCC2 requires its interaction with
two serine-threonine kinases, WNK3 (with-no-lysine kinase)
and SPAK (a Ste20-type kinase). WNK3 is positioned up-
stream of SPAK and seems to be the chloride-sensitive ki-
nase (Ponce-Coria et al., 2008). Moreover, a binding site for
the protein-phoshatase-1 has been identified in the N termi-
nus of NKCC1, suggesting a crucial role for it in the regu-
lation of NKCC1. Interestingly, we found that neither the
SPAK kinase nor the protein phosphatase-1, the major play-
ers in the NKCC activation, coimmunoprecipitate with
MAL/VIP17 (Supplemental Figure 2). Thus, we conclude
that the observed increase in the fraction of phosphorylated
NKCC2 may be attributable to the stabilization of the co-
transporter at cell surface.
More interestingly, we showed that both glycosylation
and phosphorylation patterns of NKCC2 were significantly
increased in MAL/VIP17-overexpressing transgenic mice
compared with the their controls. MAL/VIP17-overexpres-
ing mice develop dramatically amplified renal epithelial cell
apical membranes as well as cysts in the tubular system of
the kidney, consistent with an important role of MAL/VIP17
in the genesis and development of apical plasma membranes
in the kidney (Frank et al., 2000).
It has been demonstrated that the glycosylation of NKCC2
is necessary for the correct surface expression of the cotrans-
porter and for the stabilization of its functional conformation
(Paredes et al., 2006). Indeed, the increase in the extent of
NKCC2 glycosylation and phosphorylation observed in
MAL/VIP17-overexpressing mice might be consistent with
an increase in the NKCC2 membrane stability. Further stud-
ies are needed to identify the molecular mechanism by
which MAL/VIP17 inhibits NKCC2 internalization.
One possibility is that NKCC2 phosphorylation may play
a role in the NKCC2 internalization. In fact, Western blotting
with the R5 antibody did not detect phosphorylated NKCC2
in the endocytosed material in the presence or absence of
MAL/VIP17 expression (data not shown). This may indicate
that only nonphosphorylated NKCC2 is subject to endocy-
tosis and that the phosphorylated form is not a substrate for
internalization. If this is the case, the surface stabilization of
NKCC2 induced by MAL/VIP17 expression may be due
directly to the effects of MAL/VIP17 expression on NKCC2
phosphorylation. It is also possible, however, that the quan-
tity of p-NKCC2 present in the endocytosed pool is below
our limit of detection with the R5 antibody. Future experi-
ments are required to choose among these possibilities.
Because MAL/VIP17 associates with sphingolipid-choles-
terol rafts, another possibility is that MAL/VIP17 recruits its
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interacting partners into these membrane domains. We
showed here that NKCC2 is mainly expressed in mild de-
tergent-resistant membrane domains in both LLC-PK1 cells
and rat kidney medullae.
Interestingly, the expression of MAL/VIP17 in LLC-PK1
cells did not induce any further appreciable recruitment of
c-NKCC2 into DRMs. Thus, the presence of NKCC2 in these
membrane subdomains seems to be independent of MAL/
VIP17.
It is believed that MAL/VIP17 plays its role in apical
sorting processes by recruiting apical cargo into DRMs
(Cheong et al., 1999; Puertollano et al., 1999). However, ap-
proximately half of the proteins that have been shown to
require MAL/VIP17 for their apical sorting are not found in
these DRMs (Martin-Belmonte et al., 2000, 2001). Therefore,
we and others (Kamsteeg et al., 2007) suggest that one role of
MAL/VIP17 in the apical sorting may be attributable to the
stabilization and retention of MAL/VIP17 partner proteins
at the apical surface after their initial apical delivery.
The predicted membrane-spanning helices of MAL/
VIP17 constitute the MARVEL domain, which is found in
20 open reading frames in the human genome (Sa´nchez-
Pulido et al., 2002). The MARVEL domain is also found in
the tight junction-localized protein occludin and in the syn-
aptic-membrane-localized proteins synaptophysin and syn-
aptogyrin. Thus, a common feature of proteins containing
the MARVEL domain is localization to specialized domains
within surface membranes.
Moreover, there is evidence for a potential role for MAL in
the formation and stabilization of membrane domains that
may potentially serve as apical sorting platforms, and as a
possible membrane-thickness–stabilizing entity (Goldstein
Magal et al., 2009). Indeed, we cannot exclude that MAL/
VIP17 recruits the NKCC2 cotransporter into a MAL/VIP17-
enriched specialized membrane domain in which additional
partner proteins are included and involved in NKCC2 reg-
ulation. Proteomic approaches are in progress to identify
other components of the MAL/VIP17 “interactome” in the
kidney.
In conclusion, we identified the tetraspan-member family
MAL/VIP17 as new player in the regulation of the func-
tional expression of NKCC2 at the apical plasma membrane
in the kidney. The interaction between MAL/VIP17 and
NKCC2 might play an important role in the physiological
regulation of body salt and water homeostasis as well as in
the pathogenesis of hypertension.
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